Skip to main content

Table 1 Reported cases of hepatectomy for metachronous liver metastases from non-small cell lung cancer

From: Hepatectomy for rapidly growing solitary liver metastasis from non-small cell lung cancer: a case report

No.

Author

Age

Sex

Primary lesion

Time interval (months)

Liver metastases

Management

Stage

Histological type

Adjuvant therapy

Location

Size (cm)

Number

Hepatectomy procedure

Treatment for recurrences

Outcome (months)

1

Di Carlo

69

F

L

NA

AD

48

S7

5

1

P

Alive (36)

2

Takagi

46

M

L

NA

Pleo

10

S6

10

1

S

CT

Dead (12)

3

Nagashima

71

M

L

IB

AD

6

S5/S6

2.5/0.4

2

P

Alive(62)

4

Nikkumi

60

M

L

IB

SQ

RT

12

S7

7

1

P

Surg

Alive (73)

5

Kim

55

M

Pn*

IA

SQ

7

caudate

NA

1

S

Alive (60)

6

Ercolani

52

M

L

NA

AD

CT

24

S6

5

1

S

Dead(36)

7

Ercolani

60

F

L

NA

AD

CT

18

NA

6

1

L

Alive (NA)

8

Ileana

56

M

L*

IIIA

LCNEC

24

NA

NA

3

L

CT

Alive(21)

9

Ileana

70

F

CCRT

IIIB

AD

9

NA

3

1

NA

CT

Dead (5.5)

10

Ueda

77

M

L

IIA

LA

CT, RT

8

S8

5

1

S

Alive (6)

11

Ueda

65

F

L

IIIA

AD

CT, RT

20

S7

2

1

S

Dead (20)

12

Higaki

77

M

P

IIB

SQ

10

S2

1

1

S

RT, BI, CT

Alive(33)

13

Watanabe

71

M

L

IA

AD

11

S6

3.5

1

P

EGFRTKI

Alive (6)

14

Ishige

NA

M

Surg

IIIA

SQ

1.6

NA

4.5

1

S

RT

Dead(15.2)

15

Ishige

NA

M

Surg

IB

SQ

15

NA

4

4

P

CT

Alive(23.4)

16

Ishige

NA

M

Surg

IIIA

SQ

CT

8

NA

4

1

S

CT

Dead(24.5)

17

Ishige

NA

M

Surg

IA

SQ

7

NA

2.3

3

S

NA

Alive(30.2)

18

Ishige

NA

M

Surg

IB

SQ

CT

13

NA

3

1

P

CT

Alive(26.2)

19

Ishige

NA

F

Surg

IB

AD

42

NA

1.9

4

P

Alive(24)

20

Ishige

NA

M

Surg

IB

LA

7.4

NA

7.5

1

S

Dead(16.5)

21

Present case

74

M

L

IB

SQ

14

S5

9.6

1

L

Alive (41)

  1. NA not available, AD adenocarcinoma, SQ squamous cell carcinoma, LA large cell carcinoma, LCNEC large cell neuroendocrine carcinoma, Pleo pleomorphic carcinoma, CT chemotherapy, RT radiotherapy, CCRT concurrent chemoradiotherapy, time interval the interval of time between primary lesion treatment and hepatectomy, P partial resection, S segmentectomy or sectionectomy, Surg surgery, L lobectomy, Pn pneumonectomy, BI bronchoscopic intervention, EGFRTKI epidermal growth factor receptor tyrosine kinase inhibitor
  2. Italic font indicates the pathological stage
  3. *Induction therapy was administered